MoneyWorks4Me

Biocon - Quaterly Results

23 May 2023 Evaluate
A slight decline in the revenue of Rs. 5067.00 millions was seen for the March 2023 quarter as against Rs. 5177.00 millions during year-ago period.Net Profit for the quarter ended March 2023 zoomed to 4652.76% from Rs. 381.00 millions to Rs. 18108.00  millions.Operating profit for the quarter ended March 2023 decreased to 200.00 millions as compared to 873.00 millions of corresponding quarter ended March 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 5067.00 5177.00 -2.12 19929.00 17382.00 14.65 19929.00 17382.00 14.65
Other Income 640.00 608.00 5.26 2714.00 1872.00 44.98 2714.00 1872.00 44.98
PBIDT 200.00 873.00 -77.09 2949.00 2483.00 18.77 2949.00 2483.00 18.77
Interest 481.00 0.00 0.00 696.00 4.00 17300.00 696.00 4.00 17300.00
PBDT 18255.00 873.00 1991.07 30881.00 2479.00 1145.70 30881.00 2479.00 1145.70
Depreciation 294.00 281.00 4.63 1169.00 1082.00 8.04 1169.00 1082.00 8.04
PBT 17961.00 592.00 2933.95 29712.00 1397.00 2026.84 29712.00 1397.00 2026.84
TAX -147.00 211.00 -169.67 1228.00 536.00 129.10 1228.00 536.00 129.10
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 18108.00 381.00 4652.76 28484.00 861.00 3208.25 28484.00 861.00 3208.25
Equity 6003.00 6003.00 0.00 6003.00 6003.00 0.00 6003.00 6003.00 0.00
PBIDTM(%) 3.95 16.86 -76.59 14.80 14.28 3.59 14.80 14.28 3.59
Peers
Company Name CMP
Sun Pharma. Inds. 1782.00
Dr. Reddys Labs. 1208.00
Cipla 1334.00
Lupin 2010.00
Zydus Lifesciences 1138.50
View more..